logo

For the Inventor, By the Inventor

Amesbury, MA, United States of America

Christine Miller

This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignees: Surface Oncology, Inc., Adimab, LLC, Novartis Ag. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine Miller. Retrieved from https://idiyas.com/inventor/christine-miller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 12.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Amesbury, MA (US) (2022)
  • Cambridge, MA (US) (2022)

Company Filing History:

goldMedal3 out of 13 
 
Surface Oncology, Inc.
 patents
silverMedal2 out of 52 
 
Adimab, LLC
 patents
bronzeMedal1 out of 3,978 
 
Novartis Ag
 patents
where one patent can have more than one assignee

Years Active: 2022-2026

Loading Chart...
4 patents (USPTO):Explore Patents
1. 12630624 - ANTI-IL-27 ANTIBODIES AND USES THEREOF (2026-05-19),
2. 12358978 - Anti-IL-27 antibodies and uses thereof (2025-07-15),
3. 11332524 - Anti-IL-27 antibodies and uses thereof (2022-05-17),
4. 11312783 - Antibody molecules to CD73 and uses thereof (2022-04-26),

Title: Christine Miller: Innovator in Antibody Research

Introduction

Christine Miller is a prominent inventor based in Amesbury, MA (US). She has made significant contributions to the field of antibody research, particularly in the development of anti-IL-27 antibodies. With a total of 4 patents to her name, her work has the potential to impact the treatment of various diseases, including cancer.

Latest Patents

Among her latest patents is the innovative work on anti-IL-27 antibodies and their uses. This patent discloses methods for treating or ameliorating symptoms of diseases such as cancer by administering these antibodies or their antigen-binding portions. Additionally, the patent outlines methods for detecting IL-27 in subjects or samples, showcasing the versatility and importance of her research.

Career Highlights

Christine has worked with notable companies in the biotechnology sector, including Surface Oncology, Inc. and Adimab, LLC. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her coworkers include Jonathan Hill and Scott C Chappel, who have also played significant roles in advancing research in antibody therapies.

Conclusion

Christine Miller's innovative work in the development of anti-IL-27 antibodies positions her as a key figure in the fight against cancer and other diseases. Her contributions to the field of biotechnology continue to pave the way for new therapeutic approaches.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…